KR870700608A - 아미노-살리실산 유도체 및 제약 조성물 - Google Patents
아미노-살리실산 유도체 및 제약 조성물Info
- Publication number
- KR870700608A KR870700608A KR1019860700507A KR860700507A KR870700608A KR 870700608 A KR870700608 A KR 870700608A KR 1019860700507 A KR1019860700507 A KR 1019860700507A KR 860700507 A KR860700507 A KR 860700507A KR 870700608 A KR870700608 A KR 870700608A
- Authority
- KR
- South Korea
- Prior art keywords
- amino
- pharmaceutical compositions
- acid derivatives
- salicylic acid
- salicylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT23799/84A IT1196348B (it) | 1984-11-29 | 1984-11-29 | Composti ad attivita'antiinfiammatoria |
PCT/EP1985/000645 WO1986003199A1 (en) | 1984-11-29 | 1985-11-26 | Amino-salicylic acid derivatives and pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
KR870700608A true KR870700608A (ko) | 1987-12-30 |
Family
ID=11210091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019860700507A KR870700608A (ko) | 1984-11-29 | 1986-07-28 | 아미노-살리실산 유도체 및 제약 조성물 |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0236329A1 (da) |
JP (1) | JPS62501703A (da) |
KR (1) | KR870700608A (da) |
CN (1) | CN85109554A (da) |
AU (1) | AU5231186A (da) |
DK (1) | DK346486A (da) |
ES (1) | ES8701717A1 (da) |
GR (1) | GR852834B (da) |
IT (1) | IT1196348B (da) |
PT (1) | PT81566B (da) |
WO (1) | WO1986003199A1 (da) |
ZA (1) | ZA859035B (da) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9017710D0 (en) * | 1990-08-13 | 1990-09-26 | May & Baker Ltd | New compositions of matter |
GB9017711D0 (en) * | 1990-08-13 | 1990-09-26 | May & Baker Ltd | New compositions of matter |
IT1244873B (it) * | 1990-09-12 | 1994-09-12 | Depha Team Srl | Derivati dell'acido 5-aminosalicilico (5-asa) per la terapia delle infiammazioni croniche intestinali |
US5366987A (en) * | 1991-08-22 | 1994-11-22 | Warner-Lambert Company | Isoxazolyl-substituted alkyl amide ACAT inhibitors |
FR2738150B1 (fr) * | 1995-09-01 | 1997-10-31 | Synthelabo | Utilisation de la sulphasalazine et de ses metabolites pour la fabrication d'un medicament utile dans le traitement de l'insuffisance veineuse et des ulceres veineux |
EP1274675B1 (en) * | 2000-04-19 | 2004-09-01 | Neurotech Co., Ltd. | Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
US6964982B2 (en) | 2000-04-20 | 2005-11-15 | Neurotech Co., Ltd. | Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
DE60114724T2 (de) * | 2000-07-18 | 2006-06-01 | Dainichiseika Color & Chemicals Mfg. Co., Ltd. | Blutflussverbesserer und Mittel zur Vorbeugung oder Heilung von Thrombose |
EP1225449B1 (en) | 2001-01-19 | 2008-10-22 | Apex Biotechnology Corporation | Non-enzymatic disposable electrode strip comprising a surfactant for detecting uric acid or hemoglobin; method for producing the same and its use |
BR0212510A (pt) | 2001-09-14 | 2004-08-24 | Methylgene Inc | Inibidor de histona desacetilase, composto e composição |
JP4113957B2 (ja) | 2002-06-19 | 2008-07-09 | アムコア ファーマ, インコーポレイテッド | テトラフルオロベンジル誘導体及びこれを含有する急性及び退行性脳神経系疾患の予防及び治療用薬学的組成物 |
KR100668111B1 (ko) | 2005-07-28 | 2007-01-12 | (주)에스에이치제약 | 강력한 항산화 효과를 가짐으로써 급성 및 퇴행성 뇌신경계질환의 예방 및 치료에 이용 가능한 신규물질인아미노살리실산 유도체와 그 염의 제조방법 |
KR101333753B1 (ko) * | 2006-04-13 | 2013-11-28 | 주식회사 아라온테크 | 세포 손상 및 염증 질환의 치료 또는 예방용 약학 조성물 |
CN100422721C (zh) * | 2006-05-26 | 2008-10-01 | 南京大学 | 一种利用糖基萘酚的铝离子检测方法 |
JP5470046B2 (ja) * | 2007-10-23 | 2014-04-16 | 株式会社医薬分子設計研究所 | Pai−1産生抑制剤 |
KR100852962B1 (ko) | 2007-11-12 | 2008-08-20 | 주식회사 뉴로테크 | 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법 |
US9085527B2 (en) | 2008-07-08 | 2015-07-21 | Catabasis Pharmaceuticals, Inc. | Fatty acid acylated salicylates and their uses |
CA2729186C (en) * | 2008-07-08 | 2018-01-16 | Catabasis Pharmaceuticals, Inc. | Fatty acid acetylated salicylates and their uses |
KR101204108B1 (ko) * | 2009-02-09 | 2012-11-22 | 주식회사 지엔티파마 | 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도 |
MX2012002710A (es) | 2009-09-01 | 2012-04-19 | Catabasis Pharmaceuticals Inc | Conjugados de niacina y acidos grasos y sus usos. |
USRE46608E1 (en) | 2009-09-01 | 2017-11-14 | Catabasis Pharmaceuticals, Inc. | Fatty acid niacin conjugates and their uses |
CN104603100A (zh) * | 2012-05-23 | 2015-05-06 | 塞利克斯比奥私人有限公司 | 用于治疗炎症性肠病的组合物和方法 |
WO2014070859A1 (en) * | 2012-10-30 | 2014-05-08 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Stat3 dimerization inhibitors |
KR20210107828A (ko) * | 2018-12-28 | 2021-09-01 | 주식회사 지엔티파마 | 신경퇴행성 질환 치료를 위한 조성물 및 방법 |
CN111116395B (zh) * | 2019-12-27 | 2023-04-07 | 湖北工业大学 | 多碘代芳香酸类化合物及其在抗腺病毒7型中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR4546M (da) * | 1964-06-09 | 1966-11-02 | ||
NL7008623A (da) * | 1969-06-25 | 1970-12-29 | ||
JPS5640710B2 (da) * | 1973-01-18 | 1981-09-22 | ||
JPS6056130B2 (ja) * | 1978-03-20 | 1985-12-09 | 久光製薬株式会社 | 新規なサリチル酸誘導体 |
US4536346A (en) * | 1983-05-06 | 1985-08-20 | American Cyanamid Company | Aralkanamidophenyl compounds |
-
1984
- 1984-11-29 IT IT23799/84A patent/IT1196348B/it active
-
1985
- 1985-11-25 GR GR852834A patent/GR852834B/el unknown
- 1985-11-26 ZA ZA859035A patent/ZA859035B/xx unknown
- 1985-11-26 WO PCT/EP1985/000645 patent/WO1986003199A1/en not_active Application Discontinuation
- 1985-11-26 AU AU52311/86A patent/AU5231186A/en not_active Abandoned
- 1985-11-26 JP JP61500163A patent/JPS62501703A/ja active Pending
- 1985-11-26 EP EP86900097A patent/EP0236329A1/en not_active Withdrawn
- 1985-11-27 PT PT81566A patent/PT81566B/pt unknown
- 1985-11-27 CN CN198585109554A patent/CN85109554A/zh active Pending
- 1985-11-28 ES ES549359A patent/ES8701717A1/es not_active Expired
-
1986
- 1986-07-21 DK DK346486A patent/DK346486A/da not_active Application Discontinuation
- 1986-07-28 KR KR1019860700507A patent/KR870700608A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK346486D0 (da) | 1986-07-21 |
IT1196348B (it) | 1988-11-16 |
JPS62501703A (ja) | 1987-07-09 |
ES549359A0 (es) | 1986-12-01 |
CN85109554A (zh) | 1986-07-23 |
IT8423799A0 (it) | 1984-11-29 |
WO1986003199A1 (en) | 1986-06-05 |
AU5231186A (en) | 1986-06-18 |
PT81566A (en) | 1985-12-01 |
DK346486A (da) | 1986-07-21 |
ES8701717A1 (es) | 1986-12-01 |
GR852834B (da) | 1986-03-27 |
EP0236329A1 (en) | 1987-09-16 |
PT81566B (en) | 1987-04-07 |
ZA859035B (en) | 1986-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR870700608A (ko) | 아미노-살리실산 유도체 및 제약 조성물 | |
DK330287A (da) | Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme | |
NZ211031A (en) | 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions | |
NZ218588A (en) | Benzoic acid derivatives and pharmaceutical compositions | |
IT1214683B (it) | Composizioni farmaceutiche nasali | |
NZ212499A (en) | Substituted benzamide derivatives and pharmaceutical compositions | |
KR870700618A (ko) | 크로모글릭산유도체와 그 제조방법 및 약학적 조성물 | |
IT1209615B (it) | Composizione farmaceutica | |
NZ210818A (en) | 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions | |
IL72157A (en) | 6-alpha-hydroxyethyl-2-substituted-2-penem-3-carboxylic acid derivatives and pharmaceutical compositions comprising them | |
NZ216546A (en) | Glycerol derivatives and pharmaceutical compositions | |
NZ224923A (en) | 2-methoxymethyl-penem-3-carboxylic acid derivatives and pharmaceutical compositions | |
NZ215174A (en) | Barbituric acid derivatives and pharmaceutical compositions | |
NZ212868A (en) | Phenylnonatetraenoic acid derivatives and pharmaceutical compositions and intermediates therefor | |
DK99085D0 (da) | Farmaceutiske praeparater indeholdende a-vitaminsyrederivater | |
NZ214284A (en) | Benzamide derivatives and pharmaceutical compositions | |
NZ221018A (en) | 2-penem-3-carboxylic acid derivatives and pharmaceutical compositions | |
DK317985A (da) | Aminoeburnancarboxylsyrederivater | |
NZ210817A (en) | N-hydroxy-alkoxynaphthalinalkanamine derivatives and pharmaceutical compositions | |
IT1216814B (it) | Composizioni farmaceutiche | |
PH24338A (en) | Nitroapovincaminic acid derivatives and pharmaceutical compositions containing them | |
IT1203737B (it) | Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli | |
IT8547703A1 (it) | Composizioni farmaceutiche comprendenti la bromocriptina | |
IT1200467B (it) | Formulazione farmaceutica | |
NO850386L (no) | N-substituerte aminopropansulfonsyrederivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |